Molecular Devices Launches Fura-2 QBT Calcium Kit
Molecular Devices® today announced the launch of its Fura-2 QBT Calcium Kit. This new kit combines the calcium indicator Fura-2 with Molecular Devices’ proprietary masking technology to provide a fast, simple and reliable ratiometric fluorescence-based assay for detecting and quantitating changes in intracellular calcium.
Utilising Molecular Devices’ masking technology, the Fura-2 QBT Calcium Kit significantly reduces background fluorescence in media around the cells, enabling researchers to more easily detect signal from within the cell, giving more accurate results. Moreover, the new kit eliminates the need for wash protocols, thus saving time and further improving data quality.
Leveraging the advantages of Fura-2 over other calcium indicators, the dye is excited at two different wavelengths, enabling ratiometric measurement of calcium flux to minimize the impact of assay variances caused by uneven dye loading, leakage or cell density. The Fura-2 QBT Calcium Kit enables detection of the largest signal window available for Fura-2, and allows scientists to interrogate low-density, weakly or non-adherent cells.
Kevin Chance, President of Molecular Devices, commented: “Molecular Devices is fully committed to providing fully validated assay solutions, including tailored reagents and kits. We are continually discussing our customers’ needs in order to develop a range of reagents, instruments and assay protocols that fully support their research. We will be expanding our range of reagents over the coming months delivering not only the complete solution, but individual components for maximum flexibility and convenience.”
The Fura-2 QBT Calcium Kit is validated for use on FlexStation 3 and FLIPR Tetra Systems.
Related News
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance